FNY Investment Advisers’s Transmedics TMDX Stock Holding History

FNY Investment Advisers’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-305	Closed	-$34K	–	1465
2025 Q3	$34K	Buy	+305	New	+$35.7K	0.01%	585
2022 Q3	–	Sell	-990	Closed	-$31K	–	842
2022 Q2	$31K	Buy	+990	New	+$26.4K	0.02%	281

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

FNY Investment Advisers's TMDX Position: Q4 2025 in Review

FNY Investment Advisers sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 305 shares — an estimated $34K sold.

FNY Investment Advisers first reported a position in TMDX in Q2 2022 and held it in 2 quarters. The position peaked at $34K in Q3 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

FNY Investment Advisers reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
FNY Investment Advisers sold 305 Transmedics shares in Q4 2025, an estimated $34K.
FNY Investment Advisers first reported a position in Transmedics in Q2 2022 and held it in 2 quarters.
FNY Investment Advisers's Transmedics position peaked at $34K in Q3 2025.
428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.